Company Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
It operates in two segments, Proprietary Products and Contract-Manufactured Products.
The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.
This segment serves biologic, generic, and pharmaceutical drug companies.
The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
It serves pharmaceutical, diagnostic, and medical device companies.
The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors.
West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Country | United States |
IPO Date | Mar 17, 1980 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 10,600 |
CEO | Eric M. Green |
Contact Details
Address: 530 Herman O. West Drive Exton, Pennsylvania United States | |
Website | https://www.westpharma.com |
Stock Details
Ticker Symbol | WST |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000105770 |
CUSIP Number | 955306105 |
ISIN Number | US9553061055 |
Employer ID | 23-1210010 |
SIC Code | 3060 |
Key Executives
Name | Position |
---|---|
Eric M. Green | Non-Independent Chair of the Board, President & Chief Executive Officer |
Bernard J. Birkett | Senior Vice President & Chief Financial Officer |
Silji Abraham | Senior Vice President & Chief Technology Officer |
Annette F. Favorite | Chief Human Resources Officer & Senior Vice President |
Chad R. Winters | Vice President, Chief Accounting Officer & Corporate Controller |
Cindy Reiss-Clark | Senior Vice President & Chief Commercial Officer |
John P. Sweeney C.F.A. | Head of Investor Relations |
Kimberly Banks MacKay | Senior Vice President, General Counsel & Company Secretary |
Michele Polinsky | Vice President of Global Communications |
Rudy Poussot | Senior Vice President of Strategy & Corporate Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 11, 2024 | 8-K | Current Report |
Oct 31, 2024 | 4 | Filing |
Oct 31, 2024 | 4 | Filing |
Oct 24, 2024 | 10-Q | Quarterly Report |
Oct 24, 2024 | 8-K | Current Report |
Oct 23, 2024 | S-8 POS | Filing |
Oct 23, 2024 | S-8 POS | Filing |
Aug 21, 2024 | 4 | Filing |
Aug 21, 2024 | 4 | Filing |
Aug 08, 2024 | 4 | Filing |